Joined Today: 17

GERN Geron, Stock Message Board

All Messages

GERN Message Board Home | Join The GERN Group |

#51: U.S. Patent Office Upholds Key Human Embryonic Stem Cell Patent
TheMachine	February 28, 2008 09:33:53 AM
Geron Corporation (Nasdaq:GERN) announced today that the U.S. Patent Office has upheld the validity of a key patent for human embryonic stem cells. The patent is... view message ignore post recommend post

#50: Start Licensing, Inc. Challenges Korean Company's Provision of Dog Cloning Services
TheMachine	February 28, 2008 09:27:45 AM
Patent Licensee Will Take Legal Action to Protect Rights if Necessary Today Start Licensing, Inc. (Start) announced that it controls key patents in Korea that cover... view message ignore post recommend post

#49: Geron Ranked in Biotechnology Patent Scorecard Published in The Wall Street Journal
TheMachine	February 28, 2008 09:27:08 AM
Geron Corporation (NASDAQ:GERN) was ranked number 5 of companies listed in the biotechnology patent scorecard published in the Feb. 12 issue of The Wall Street Journal.... view message ignore post recommend post

#48: Geron Corporation to Present at BIO CEO & Investor Conference
TheMachine	February 28, 2008 09:26:41 AM
Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., Geron’s president and chief executive officer, will present an update of the... view message ignore post recommend post

#47: Geron's Second U.S. Patent for Production of Pancreatic Islets from Human Embryonic Stem Cells Strengthens Company's Intellectual Property Position
TheMachine	February 28, 2008 09:26:10 AM
Geron Corporation (Nasdaq:GERN) announced today that it has received U.S. Patent 7,326,572 with claims covering a widely used method for producing endoderm cells from... view message ignore post recommend post

#46: Journal of Neuroimmunology Publishes Study Results Showing That Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
NewsBot	November 20, 2007 11:36:15 PM
Data Indicate Short Courses of Low-Dose Immunosuppression May be Sufficient to Prevent Immune Rejection of GRNOPC1 Geron Corporation (Nasdaq:GERN) today announced the publication of study... view message ignore post recommend post

#45: GERN News Geron Supports WARF's Claims to Human Embryonic Stem Cell Patents
NewsBot	April 2, 2007 06:39:00 PM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) supports the position of the Wisconsin Alumni Research Foundation (WARF) that U.S. patents covering Dr. James... view message ignore post recommend post

#44: GERN News Geron Corporation Reports Fourth Quarter and Annual 2006 Financial Results and Highlights
NewsBot	March 16, 2007 04:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2006. As disclosed on March 9,... view message ignore post recommend post

#43: GERN News Geron Grants License to Asia Biotech Corporation
NewsBot	March 12, 2007 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced it has granted an exclusive global license to Asia Biotech Corporation for the development of... view message ignore post recommend post

#42: GERN News Geron to Restate Financial Results of Prior Periods
NewsBot	March 9, 2007 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced that the company will restate its financial statements for the 2005, 2004 and 2003 fiscal years as... view message ignore post recommend post

#41: GERN News Geron Corporation Announces Exercise of Warrants for $15.0 Million of Proceeds
NewsBot	February 27, 2007 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the exercise of warrants to purchase 1,875,000 shares of common stock at $8.00 per share for gross... view message ignore post recommend post

#40: GERN News Unique Structure of Geron's Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic Activity in Lung Cancer Cells
NewsBot	February 15, 2007 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data that show specific structural elements of GRN163L contribute to... view message ignore post recommend post

#39: GERN News Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
NewsBot	January 17, 2007 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today reported that studies show GRNOPC1, the company’s human embryonic stem cell (hESC)-based... view message ignore post recommend post

#38: GERN News Geron's Telomerase Inhibitor Drug May Benefit Breast Cancer Patients Receiving Radiation Therapy
NewsBot	December 19, 2006 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today reported that its telomerase inhibitor drug, GRN163L, may benefit breast cancer patients receiving radiation... view message ignore post recommend post

#37: GERN News Geron Announces Direct Equity Issuance
NewsBot	December 14, 2006 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced that it has entered into a definitive agreement to sell common stock to institutional investors at... view message ignore post recommend post

Group Home | Login if you want to post a message